Drug Profile
Darbepoetin alfa biosimilar - Hetero Drugs
Alternative Names: ActoriseLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Hetero Drugs
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 28 Nov 2020 No recent reports of development identified for phase-I development in Anaemia(In volunteers) in India (IV, Injection)
- 20 Jul 2020 PSK Pharma plans a phase I for Anaemia (In volunteers) in India (CTRI2020-07-026718)
- 28 Nov 2019 No recent reports of development identified for phase-I development in Anaemia(In volunteers) in India (IV, Injection)